Atlas Trials

A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide

Clinical trial NCT04407234 · COMPLETED

Trial details

NCT number
NCT04407234
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
OverweightObesityDiabetes Mellitus, Type 2
Start date
2020-09-15
Primary completion
2021-01-07
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.